Scholarlink

<p>Myocardial infarction (MI) is the most lethal cardiovascular disease and poses a critical threat to global health. While current MI therapies partially improve cardiac function, advanced precision therapies with translational potential capable of interrupting the vicious pathological cycles remain a pivotal challenge to be addressed. Here, based on a Mn/Se nanoheterostructure that meets human elemental requirements, we constructed a PMS@ME nanotherapeutic system for achieving efficient post-MI repair. Polydopamine was incorporated to synergistically enhance biocompatibility and therapeutic efficacy. The surface is modified with exosomes derived from macrophages that highly express adhesion receptors, enabling precise targeting to the myocardial injury area. PMS@ME administration promotes cardiomyocyte survival, extracellular repair, and mitochondrial homeostasis, while suppressing oxidative damage and immune-inflammatory disorders, achieving preserved cardiac function. Importantly, PMS@ME can induce cardiomyocyte to restart the cell cycle and promotes post-MI cardiomyocyte regeneration by inhibiting the Hippo signaling pathway. These findings demonstrate the potential of the PMS@ME system in MI treatment, offering a blueprint for designing multifunctional nanotherapies tailored to human elemental essentials.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Macrophage exosome-modified Mn/Se nanoheterostructure induces post-infarction cardiomyocyte regeneration and immunometabolic microenvironment repair

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月24日

查看全文
  • Linghuan Guo,
  • Zhi Xiong,
  • Kai Sheng,
  • Qiang Zhang,
  • Jiahui Cheng,
  • Lingling Xu,
  • Wen Wang,
  • Guoyang Zhang,
  • Tingting Yao,
  • Dan Wang,
  • Xiaoer Wei,
  • Mingkang Wang,
  • Yang Lyu,
  • Xinxin Zhao,
  • Lixian Jiang,
  • Xiaojun Cai,
  • Yuanyi Zheng,
  • Lidan Liu,
  • Yan Zhou,
  • Bo Li,
  • Yuehua Li

摘要

Myocardial infarction (MI) is the most lethal cardiovascular disease and poses a critical threat to global health. While current MI therapies partially improve cardiac function, advanced precision therapies with translational potential capable of interrupting the vicious pathological cycles remain a pivotal challenge to be addressed. Here, based on a Mn/Se nanoheterostructure that meets human elemental requirements, we constructed a PMS@ME nanotherapeutic system for achieving efficient post-MI repair. Polydopamine was incorporated to synergistically enhance biocompatibility and therapeutic efficacy. The surface is modified with exosomes derived from macrophages that highly express adhesion receptors, enabling precise targeting to the myocardial injury area. PMS@ME administration promotes cardiomyocyte survival, extracellular repair, and mitochondrial homeostasis, while suppressing oxidative damage and immune-inflammatory disorders, achieving preserved cardiac function. Importantly, PMS@ME can induce cardiomyocyte to restart the cell cycle and promotes post-MI cardiomyocyte regeneration by inhibiting the Hippo signaling pathway. These findings demonstrate the potential of the PMS@ME system in MI treatment, offering a blueprint for designing multifunctional nanotherapies tailored to human elemental essentials.

Graphical Abstract